TY - JOUR
T1 - Genetic Risk Stratification of Primary Open-Angle Glaucoma in Japanese Individuals
AU - Biobank Japan project
AU - Japan Glaucoma Society Omics Group
AU - Genomic Research Committee of the Japanese Ophthalmological Society
AU - Akiyama, Masato
AU - Tamiya, Gen
AU - Fujiwara, Kohta
AU - Shiga, Yukihiro
AU - Yokoyama, Yu
AU - Hashimoto, Kazuki
AU - Sato, Masataka
AU - Sato, Kota
AU - Narita, Akira
AU - Hashimoto, Sawako
AU - Ueda, Emi
AU - Furuta, Yoshihiko
AU - Hata, Jun
AU - Miyake, Masahiro
AU - Ikeda, Hanako O.
AU - Suda, Kenji
AU - Numa, Shogo
AU - Mori, Yuki
AU - Morino, Kazuya
AU - Murakami, Yusuke
AU - Shimokawa, Sakurako
AU - Nakamura, Shun
AU - Yawata, Nobuyo
AU - Fujisawa, Kimihiko
AU - Yamana, Satoshi
AU - Mori, Kenichiro
AU - Ikeda, Yasuhiro
AU - Miyata, Kazunori
AU - Mori, Keisuke
AU - Ogino, Ken
AU - Koyanagi, Yoshito
AU - Kamatani, Yoichiro
AU - Matsuda, Koichi
AU - Yamanashi, Yuji
AU - Furukawa, Yoichi
AU - Morisaki, Takayuki
AU - Okada, Yukinori
AU - Murakami, Yoshinori
AU - Muto, Kaori
AU - Nagai, Akiko
AU - Nakamura, Yusuke
AU - Obara, Wataru
AU - Yamaji, Ken
AU - Takahashi, Kazuhisa
AU - Asai, Satoshi
AU - Takahashi, Yasuo
AU - Higashiue, Shinichi
AU - Kobayashi, Shuzo
AU - Yamaguchi, Hiroki
AU - Ninomiya, Toshiharu
N1 - Publisher Copyright:
© 2024 American Academy of Ophthalmology
PY - 2024/11
Y1 - 2024/11
N2 - Purpose: To assess the impact of genetic risk estimation for primary open-angle glaucoma (POAG) in Japanese individuals. Design: Cross-sectional analysis. Participants: Genetic risk scores (GRSs) were constructed based on a genome-wide association study (GWAS) of POAG in Japanese people. A total of 3625 Japanese individuals, including 1191 patients and 2434 controls (Japanese Tohoku), were used for the model selection. We also evaluated the discriminative accuracy of constructed GRSs in a dataset comprising 1034 patients and 1147 controls (the Japan Glaucoma Society Omics Group [JGS-OG] and the Genomic Research Committee of the Japanese Ophthalmological Society [GRC-JOS]) and 1900 participants from a population-based study (Hisayama Study). Methods: We evaluated 2 types of GRSs: polygenic risk scores using the pruning and thresholding procedure and a GRS using variants associated with POAG in the GWAS of the International Glaucoma Genetics Consortium (IGGC). We selected the model with the highest areas under the receiver operating characteristic curve (AUC). In the population-based study, we evaluated the correlations between GRS and ocular measurements. Main Outcome Measure: Proportion of patients with POAG after stratification according to the GRS. Results: We found that a GRS using 98 variants, which showed genome-wide significance in the IGGC, showed the best discriminative accuracy (AUC, 0.65). In the Japanese Tohoku, the proportion of patients with POAG in the top 10% individuals was significantly higher than that in the lowest 10% (odds ratio [OR], 6.15; 95% confidence interval [CI], 4.35–8.71). In the JGS-OG and GRC-JOS, we confirmed similar impact of POAG GRS (AUC, 0.64; OR [top vs. bottom decile], 5.81; 95% CI, 3.79–9.01). In the population-based study, POAG prevalence was significantly higher in the top 20% individuals of the GRS compared with the bottom 20% (9.2% vs. 5.0%). However, the discriminative accuracy was low (AUC, 0.56). The POAG GRS was correlated positively with intraocular pressure (r = 0.08: P = 4.0 × 10–4) and vertical cup-to-disc ratio (r = 0.11; P = 4.0 × 10–6). Conclusions: The GRS showed moderate discriminative accuracy for POAG in the Japanese population. However, risk stratification in the general population showed relatively weak discriminative performance. Financial Disclosure(s): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
AB - Purpose: To assess the impact of genetic risk estimation for primary open-angle glaucoma (POAG) in Japanese individuals. Design: Cross-sectional analysis. Participants: Genetic risk scores (GRSs) were constructed based on a genome-wide association study (GWAS) of POAG in Japanese people. A total of 3625 Japanese individuals, including 1191 patients and 2434 controls (Japanese Tohoku), were used for the model selection. We also evaluated the discriminative accuracy of constructed GRSs in a dataset comprising 1034 patients and 1147 controls (the Japan Glaucoma Society Omics Group [JGS-OG] and the Genomic Research Committee of the Japanese Ophthalmological Society [GRC-JOS]) and 1900 participants from a population-based study (Hisayama Study). Methods: We evaluated 2 types of GRSs: polygenic risk scores using the pruning and thresholding procedure and a GRS using variants associated with POAG in the GWAS of the International Glaucoma Genetics Consortium (IGGC). We selected the model with the highest areas under the receiver operating characteristic curve (AUC). In the population-based study, we evaluated the correlations between GRS and ocular measurements. Main Outcome Measure: Proportion of patients with POAG after stratification according to the GRS. Results: We found that a GRS using 98 variants, which showed genome-wide significance in the IGGC, showed the best discriminative accuracy (AUC, 0.65). In the Japanese Tohoku, the proportion of patients with POAG in the top 10% individuals was significantly higher than that in the lowest 10% (odds ratio [OR], 6.15; 95% confidence interval [CI], 4.35–8.71). In the JGS-OG and GRC-JOS, we confirmed similar impact of POAG GRS (AUC, 0.64; OR [top vs. bottom decile], 5.81; 95% CI, 3.79–9.01). In the population-based study, POAG prevalence was significantly higher in the top 20% individuals of the GRS compared with the bottom 20% (9.2% vs. 5.0%). However, the discriminative accuracy was low (AUC, 0.56). The POAG GRS was correlated positively with intraocular pressure (r = 0.08: P = 4.0 × 10–4) and vertical cup-to-disc ratio (r = 0.11; P = 4.0 × 10–6). Conclusions: The GRS showed moderate discriminative accuracy for POAG in the Japanese population. However, risk stratification in the general population showed relatively weak discriminative performance. Financial Disclosure(s): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
KW - Genetic risk score
KW - Genome-wide association study
KW - Precision medicine
KW - Primary open-angle glaucoma
UR - http://www.scopus.com/inward/record.url?scp=85199130977&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85199130977&partnerID=8YFLogxK
U2 - 10.1016/j.ophtha.2024.05.026
DO - 10.1016/j.ophtha.2024.05.026
M3 - Article
C2 - 39023470
AN - SCOPUS:85199130977
SN - 0161-6420
VL - 131
SP - 1271
EP - 1280
JO - Ophthalmology
JF - Ophthalmology
IS - 11
ER -